Mark F Brady

The Warren Alpert Medical School of Brown University

Affiliated withThe Warren Alpert Medical School of Brown University

Research Area

Biography

Mark F Brady has not added Biography.
If you are Mark F Brady and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 32	2008

Other Publications

Article	Year
Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecolog... Gynecologic oncology\| PubMed ID: 12504619	2003
Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncol... Gynecologic oncology\| PubMed ID: 12694669	2003
Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 12807937	2003
Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 14645424	2003
Analysis of CHEK2 gene for ovarian cancer susceptibility. Gynecologic oncology\| PubMed ID: 15385111	2004
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15459211	2004
Secondary surgical cytoreduction for advanced ovarian carcinoma. The New England journal of medicine\| PubMed ID: 15590951	2004
Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecologic oncology\| PubMed ID: 16860852	2006
Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 17008690	2006
Effects of initial graft tension on the tibiofemoral compressive forces and joint position after anterior cruciate ligament reconstruction. The American journal of sports medicine\| PubMed ID: 17218659	2007
Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia. American journal of public health\| PubMed ID: 17463375	2007
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (C... Gynecologic oncology\| PubMed ID: 17822748	2007
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 17906207	2007
Corticosteroids reduce postoperative morbidity after third molar surgery: a systematic review and meta-analysis. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons\| PubMed ID: 18718396	2008
Tibiofemoral compression force differences using laxity- and force-based initial graft tensioning techniques in the anterior cruciate ligament-reconstructed cadaveric knee. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association\| PubMed ID: 18760214	2008
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19224846	2009
Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 19877966	2009
Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 20192727	2010
Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society\| PubMed ID: 20683400	2010
Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete respon... Gynecologic oncology\| PubMed ID: 20846715	2010
Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study. Cancer\| PubMed ID: 20862744	2011
EORTC 55971: does it apply to all patients with advanced state ovarian cancer? Gynecologic oncology\| PubMed ID: 21093893	2011
Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations. Gynecologic oncology\| PubMed ID: 21276604	2011
Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study. Gynecologic oncology\| PubMed ID: 21310472	2011
A randomized phase III trial of IV carboplatin and paclitaxel Ã— 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinom... Gynecologic oncology\| PubMed ID: 21529904	2011
CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: A gynecologic oncology group study. Gynecologic oncology\| PubMed ID: 22033034	2012
Incorporation of bevacizumab in the primary treatment of ovarian cancer. The New England journal of medicine\| PubMed ID: 22204724	2011